Kenvue Inc. (KVUE)
(Delayed Data from NYSE)
$21.82 USD
+0.26 (1.21%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $21.81 -0.01 (-0.05%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
Price, Consensus and EPS Surprise
KVUE 21.82 +0.26(1.21%)
Will KVUE be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for KVUE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for KVUE
International Flavors (IFF) Q2 Earnings Top on Higher Volumes
Compared to Estimates, Kenvue (KVUE) Q2 Earnings: A Look at Key Metrics
KVUE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Kenvue (KVUE) Q2 Earnings and Revenues Beat Estimates
Analysts Estimate Kenvue (KVUE) to Report a Decline in Earnings: What to Look Out for
How Should You Play J&J (JNJ) Stock After Q2 Earnings Beat?
Other News for KVUE
Kenvue Announces Participation in the Barclays Global Consumer Staples Conference
Goldman Sachs’ favorite mutual funds positions that are overweight the Russell 1000
Nielsen read: Winners and losers in the household personal care sector
Kenvue Introduces Patented Micro-Peptide Technology with Neutrogena? Collagen Bank? Launch
7 Stable Dividend Stocks to Scoop Up on Discount